A best practices framework for spatial biology studies in drug discovery and development: enabling successful cohort studies using digital spatial profiling-Reference-Cited by-同舟云学术

A best practices framework for spatial biology studies in drug discovery and development: enabling successful cohort studies using digital spatial profiling

Published:2024-09-03 Issue: Volume: Page:1-20
ISSN:0147-8885
Container-title:Journal of Histotechnology
language:en
Short-container-title:Journal of Histotechnology

Author:

Krull David¹,Haynes Premi²,Kesarwani Anil¹,Tessier Julien³,Chen Benjamin J.⁴,Hunter Kelly⁵,Rodriguez Deniliz⁶,Liang Yan⁷,Mansfield Jim⁸,McClain Maxine⁷,Ramos Corinne⁹,Bonnevie Edward²,Anguiano Esperanza⁷^ORCID

Affiliation:

1. Precision Medicine, GlaxoSmithKline, Collegeville, USA

2. Cancer Immunology & Cell Therapy Thematic Research Center, Bristol Myers Squibb, Seattle, WA, USA

3. Precision Medicine and Computational Biology, Sanofi, Cambridge, USA

4. Translational Medicine, Bristol Myers Squibb, Cambridge, MA, USA

5. Molecular Pathology and Histology, ProPath-UK Ltd, Hereford, UK

6. Precision Medicine, Bristol Myers Squibb, Lawrenceville, USA

7. Spatial Platforms Product Development and Support, NanoString Technologies Inc, Seattle, USA

8. Research Business Development, Visiopharm Corp, Broomfield, USA

9. Research and Development, Aliri, Loos, France

Publisher

Informa UK Limited